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ABSTRACT   
Purpose: The aim of this work is to compare the ability of whole body MRI including 
diffusion study with that of 99m Tc-Methylene Diphosphonate Scintigraphy to detected 
skeletal metastases in patients with breast and lung cancer. 
Patients and methods: 60 patients comprising 38 females and 22 males ranging in age from 
30 to 60 years with a mean age of 48.1 years (mean age 47.3 years for females and 49 years 
for males) were enrolled in the study. 29 females are histopathologically proven cases of 
breast malignancy, 9 females and the 22 males are histopathologically proven cases of lung 
cancer.  
The patients were referred from Oncological departments to perform the whole body MR 
study and bone scan at Ain Shams University hospitals MRI units and a private center during 
the time interval from December 2008 till December 2012. 
All patients were subjected to both whole body MRI and bone scintigraphy. The whole body 
MRI was mainly obtained using 4 contiguous coronal stations for body coverage using the 
body coil and 2 contiguous sagittal stations for the spine using T1W FSE and STIR 
sequences. 48 out of 60 patients toke IV contrast and post contrast T1W imagaes with fat 
suppression were taken. The MRI examinations were performed using a superconducting 1.5 
Tesla magnet (Achieva: Philips Medical Systems). 
 
Standard skeletal Scintigraphy was performed using a planar one phase technique (delayed 
phase). The examination was done 2-3 hours after IV injection of  technicium 99m labeled 
Methylene Diphosphonate with a maximum dose of 20 mCi. 
 
Results: 42 patients out of 60 were positive for metastases based on histopathological 
verification or follow up. On MRI, 39 patients had metastases, 3 were false negative, 12 were 
true negative and 6 were false positive. On bone scan, 35 were true positive, 7 were false 
negative, 4 were false positive and 14 were true negative. 
Based on lesion detection, on comparing bone scan to WB-MRI with and without diffusion, 
bone scan  had an overall sensitivity of 85.6%, specificity 67.5 %, PPV 61.7% and NPV 
66.3%, while WB-MRI had statistical values of 73.4%, 68.8%, 78.1% and 62.6% 
respectively. 
On adding DWI, values raised to 88.9%, 82.9%, 93% and  69% respectively. 
Quantitative analysis of DWI was also included in this study revealing an overlap between the 
Low ADC values of red marrow and metastasis at the range of 0.61 to 0.69 x10
-3 mm
2/sec and 
then between metastasis and other benign pathological marrow entities at the range of 0.9 to 
1.03 x 10
-3 mm
2/sec. 
WB-MRI also detected 64 soft tissue metastatic lesions which became 71 lesions on adding 
DWI with a distribution of hepatic, pulmonary, brain, adrenal, lymph nodes, pleural, 
leptomeningeal and renal lesions. 
 
Conclusion: we don't think that WB-MRI should replace bone scan in the quest for skeletal 
metastases. However, we believe that WB-MRI should be the modality of choice when both 
skeletal and soft tissue metastases are suspected and in the follow up of a known metastatic 
patients for adequate coverage of both skeletal and soft tissue structures combined with 
qualitative and quantitative features of DWI helping assess tumors at cellular levels even prior 
to gross morphological changes verifying response to therapy as early as possible sparing 
patients precious time  from drifting with delayed decision making. 
 Wafaa Abdel Hamid 
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INTRODUCTION 
It is well recognized that metastases to the 
skeleton is by far the most common type 
of malignant bone tumors. [1] 
Evidence  of  osseous  metastasis  is  of 
clinical importance because it is essential 
for  clinical  staging  and  the  subsequent 
therapy  planning.  Localization  and 
spreading of the skeletal  metastasis  must 
be  displayed  to  identify  possibly 
threatening  complications  in  a  timely 
manner. [2] 
Metastasis of the bones tends to occur in 
areas of the red bone  marrow  with  good 
vascularization, which, therefore, explains 
the tendency of metastases to be localized 
in  the  axial  skeleton(80%  ),  the  femur 
(40%) as well as the skull and the pelvis 
(20%).  Additional  areas  of  manifestation 
are the ribs and the sternum (25-30%). [3] 
 
All existing methods of detecting skeletal 
metastases  have  certain  limitations  as 
discussed  earlier  in  our  study  based  on 
either the nature of the metastatic lesions 
(Lytic,  sclerotic  or  mixed)  or  the 
distribution  with  certain  blind  spots 
encountered  in  each  modality  or severity 
of  lesion  (early  or  established  with  a 
spectrum of changes in between). 
 
99mTc-phosphonate  based
  skeletal 
scintigraphy has been the standard method 
for the initial
 staging of bone metastases. 
However,  it  depicts bone  metastases
 at a 
relatively  advanced  stage  of  tumor 
infiltration when osteoblastic
 host reaction 
to  tumor  deposits  has  already  occurred 
rendering it a fertile environment for a vast 
number  of  studies  attempting  to  assess 
different  parameters  as  conspicuity  of 
lesions  and  the  capability  of  different 
modalities  to  accurately  characterize  the 
lesions.  
MRI  has  been  verified  to  assess  bone 
marrow metastases at significantly earlier 
stages than skeletal scintigraphy, yet  due 
to the long examination time and the high 
cost, MRI has not been able to be widely 
applied  as  the  routine  method  for  the 
screening of the entire skeletal system, it 
has been confined to regional assessments 
based  on  equivocal  findings  on  other 
imaging  modalities  or  persistence  of 
patient's  symptoms  despite  negative 
findings on other modalities. Furthermore, 
there are technical limitations exists which 
have hampered fast MR imaging.[4] 
 
New  developments  in  gradient  echo 
technology and new patient table and coil 
concepts have made MRI a method to be 
considered  for  the  evaluation  of  tumor 
patients. [5] 
Based on our results from the examination 
of  60  patients,  whole-body  MRI  using 
T1W,  STIR  &  diffusion  sequences 
through  a  moving  tabletop  and  tabletop 
extender  where  patients
  were  placed 
supine head first and were examined using 
the integrated body coil and an additional 
32  channel  phased  array  torso  coil  to 
improve signal arising from the chest and 
upper  abdomen  together  with  using  a 
circularly  polarized  spine  coil  to  receive 
high  resolution  spine  images  is  a  fast, 
dependable  alternative  to  skeletal 
scintigraphy  for  the  detection  of 
metastases of the skeletal system. 
 
Several  studies  have  compared  skeletal 
scintigraphy  and  WB-MRI  reporting 
different  sensitivities  and  specificities. 
Other studies tackled the additional role of 
DWI  in  further  detection  and 
characterization  of  skeletal  lesions 
compared to established conventional MR 
sequences. 
In  our  study  we  integrated  both  aspects 
WB-MRI compared to bone scan and the 
role of WB-DWI; the extra 25-30 minutes 
lengthening of the study, is it worth it? 
 
PATIENTS AND METHODS 
60 patients comprising 38 females and 22 
males ranging in age from 30 to 60 years 
with a mean age of 48.1 years (mean age 
47.3  years  for  females  and  49  years  for 
males)  were  enrolled  in  the  study.  29 
females  are  histopathologically  proven 
cases of breast malignancy, 9 females and 
the  22  males  are  histopathologically 
proven cases of lung cancer.  
The  patients  were  referred  from 
Oncological  departments  to  perform  the 
whole  body  MR  study  and  bone  scan  at 
Ain Shams University hospitals MRI units 
and  a  private  center  during  the  time 
interval  from  December  2008  till 
December 2012. A Comparative Study … 
202 
 
The inclusion criteria were: Age group: 30 
to  60  years,  both  sexes  are  included, 
patients  with  histopathologically  proven 
breast  and  lung  cancer  and  current 
complaint of bone aches. 
The exclusion criteria were: Children and 
elderly  patients,  lactating  and  pregnant 
females  and  patients  known  to  have  end 
stage renal disease. 
 
Bone scan imaging protocol: 
 
-  Patients  were  informed  to  be  well 
hydrated. 
-  Patients were asked to void immediately 
prior  to  study  and  frequently  after  the 
injection  of  the  radiotracer 
administration throughout the day. 
-  Patients  were  asked  to  remove  metal 
objects  before  imaging    (e.g:  watches, 
keys, jewelry, coins. etc) 
-  A 20  mCi (70 MBq) bolus  of Tc-99m 
MDP is injected intravenously. 
-  Imaging was commenced 2-4 hours after 
tracer administration. 
-  Anterior  and  Posterior  images  of  the 
whole  skeleton  were  taken  at 
counts/image. 
-  Variable spot views were taken differing 
from one patient to another (300k-500k 
counts/image). 
 
MR imaging protocol: 
 
Whole body MR studies  were performed 
on  1.5-T  superconducting  magnet 
(Achieva;  Phillips  Medical  Systems)  by 
using  a  moving  tabletop  and  tabletop 
extender.   
The patients
 were placed supine head first 
and  were  examined  using  the  integrated 
body  coil  and  an  additional  32  channel 
phased array torso coil to improve signal 
arising from the chest and upper abdomen. 
Images of the spine
 were acquired using a 
circularly  polarized  spine  coil.  Slice 
orientation was
 coronal for the trunk and 
extremities and sagittal for the spine. The 
entire MR imaging procedure
 took 60-90 
min. 
The  following  protocol  was  used  for  all 
patients,  except  for  twelve  patients  who 
weren't administered IV contrast:
 
1)   The  parameters  for  the  whole 
body coronal T1-weighted sequence were 
as follows:
 
 single-shot  turbo  spin  echo;  TR/TE, 
537/18; slice thickness, 6 mm; gap, 1 mm; 
number  of slices, 30 per station; field of 
view, 530 × 265 mm; acquisition matrix, 
208 × 287; number of signals acquired, 1; 
acquired  voxel  size,  1.27  ×  1.85  ×  6.00 
mm; reconstructed voxel size, 1.04 × 1.04 
×  6.00  mm;  acquisition  time,  127 
seconds/station, six stations total.
 
2)  Applied parameters for the whole 
body  coronal  STIR  sequence  were  as 
follows: 
 
single-shot  turbo  spin  echo;  TR/TE, 
444/64; inversion time, 165 milliseconds; 
slice thickness, 6 mm; gap, 1 mm; number 
of slices, 30 per station; field of view, 530 
× 265 mm; acquisition matrix, 336 × 120; 
number  of  signals  acquired,  2;  acquired 
voxel  size,  1.58  ×  2.21  ×  6.00  mm; 
reconstructed  voxel  size,  1.04  ×  1.04  × 
6.00  mm;  acquisition  time,  58 
seconds/station, six stations total. 
 
3)  Applied parameters for the whole 
spine  sagittal  T1W  sequence  were  as 
follows: 
 
turbo  spin-echo  images;  TR/TE,  180/10; 
bandwidth,  195  Hz/pixel;  number  of 
slices,  11;  section  thickness,  4  mm; 
intersection  gap,  0.8  mm;  echo  train 
length, three; refocusing flip angle, 180°; 
field of view, 380 × 380 cm; matrix, 177 × 
256;  are  acquired  at  two  stations 
(cervicodorsal  and  dorsolumbar  regions) 
and  are  composed  into  single  images 
through  computed  alignment.  The  total 
imaging time for both stations is 2 minutes 
12 seconds.  
4)  Applied parameters for the whole 
spine  sagittal  STIR  sequence  were  as 
follows: 
 
TR/TE,  4500/101;  bandwidth,  252 
Hz/pixel; acceleration factor, 2; number of 
sections,  11;  section  thickness,  4  mm; 
echo train length, 29; refocusing flip angle, 
150°; field of view, 380 × 380 cm; matrix, 
320  ×  320;  are  acquired  at  two  stations 
(cervicodorsal  and  dorsolumbar  regions) 
and  are  composed  into  single  images  by 
computed  alignment.  The  total  imaging 
time  for  both  stations  is  2  minutes  36 
seconds. Wafaa Abdel Hamid 
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5)  Applied  sequence  parameters  for 
axial DWI were as follows:
 
 single-shot  spin-echo  echo-planar 
imaging;  TR/TE,612/78;  inversion  time, 
180  milliseconds;  slice  thickness,  4  mm; 
gap, 0 mm; number of slices, 60; field of 
view, 450 × 360 mm; acquisition matrix, 
128  ×  81;  receiver  bandwidth,  1,874 
Hz/pixel;  motion-probing  gradients  in 
three  orthogonal  axes;  b  values,  0  and 
1,000 s/mm
2; number of signals acquired, 
3;  half-scan  factor,  0.651;  parallel 
acquisition (sensitivity encoding) factor, 2; 
echo-planar  imaging  factor,  43;  acquired 
voxel  size,  3.52  ×  4.50  ×  4.00  mm; 
reconstructed  voxel  size,  1.76  ×  1.76  × 
1.76  mm;  acquisition  time,  4  minutes  4 
seconds/station, with a total of 5 stations. 
The  total  actual  acquisition  time  for 
whole-body DWI was approximately 20–
25 minutes. 
Coronal  MIP's  and  3D  MPR's  were 
generated.  
6)  During  contrast-enhanced  whole-
body  MR  examination,  a  standard  dose 
(0.1 mmoL per kilogram of body weight) 
of  contrast  material  was  administered 
intravenously through the antecubital vein 
and  delayed  fat  suppressed  T1W  images 
were acquired.
 
Data Analysis: 
On MRI, a skeletal lesion  of  high signal 
intensity  on  STIR  image  and  low  signal 
intensity  on  T1  weighted  images  with  or 
without  avid  post  contrast  enhancement 
was  considered  to  be  a  suspected 
metastasis  furtherly  correlated  with 
restricted  diffusion  and  altered  ADC 
values to establish the diagnosis. Areas of 
abnormal uptake of 
99mTc-MDP on skeletal 
scintigraphy  that  could  not  be  definitely 
explained  by  benign  abnormalities,  e.g. 
degenerative  joint  disease,  secondary 
changes to fractures were considered to be 
suspected metastases. 
A patient was considered to have negative 
imaging  findings  when  no  bony  lesions 
meeting  the  criteria  of  malignancy  were 
identified.  Findings  of  the  whole-body 
MRI  and  the  skeletal  scintigram  were 
compared  to  the  “gold  standard”  which 
was  either  biopsy  and  histopathological 
verification (not feasible for all lesions) or 
follow up (at a 3-6 month interval). 
Another parameter was assessed which 
is  Conspicuity  and  contrast-to-noise 
ratio  to  analyse  and  compare  the 
different  MR  sequences  (T1W,  STIR 
and DWI): 
 The  MR  imaging  sequences  were 
compared  qualitatively  by  ordering  the 
sequences according to the conspicuity of 
the  bone  metastases  and  semi-
quantitatively in terms of contrast-to-noise 
ratio (CNR).   
CNRs  were  computed  according  to  the 
following  formula:  CNR  =  (SImet  − 
SIbone)/N, with SImet and SIbone defined 
as  mean  signal  intensity  inside  the  ROI 
placed on the metastasis and normal bone, 
respectively,  and  N  defined  as  noise 
signifying the standard deviation inside the 
ROI placed outside the body. 
Soft tissue lesions detected on MRI were 
compared  in  terms  of  detection  and 
characterization  before  and  after  adding 
DWI. 
Statistical  analysis:  Sensitivity, 
specificity, PPV and NPV were calculated 
for  lesion  detection  and  characterization 
by bone scan, WB-MRI with and without 
diffusion and compared. The CNRs were 
compared with a general linear model with 
repeated measures. The effect of the inner-
subject  factor  was  tested  by  using  a 
difference  with  P  <  .05  as  significant. 
Calculations  were  performed  by  using  a 
statistical  software  package  (JMP  7.0.2, 
2008)/McNemar test. 
 
RESULTS 
Our study included 60 patients comprising 
38  females  and  22  males  ranging  in  age 
from 30 to 60 years with a mean age of 
48.1  years  (mean  age  47.3  years  for 
females  and  49  years  for  males).  29 
females  are  histopathologically  proven 
cases of breast malignancy, 9 females and 
the  22  males  are  histopathologically 
proven  cases  of  lung  cancer  as 
demonstrated in table (1).  
Table  (1):  Distribution  of  the  sixty 
patients in the different age groups. 
All the patients were subjected to a whole 
body  MR  study  including  coronal  T1W, 
STIR and DWIBS sequences, axial DWIs 
were  acquired  for  the  purpose  of 
quantification  (generating  ADC  maps), 
sagittal  T1W  and  STIR  images  of  the A Comparative Study … 
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whole spine together with a post contrast 
study  within  72  hours  to  a  maximum  of 
one  week  from  scintigraphic  bone  scan 
during  the  time  interval  from  December 
2008 till December 2012. 
Twelve cases out of sixty refused contrast 
as they couldn't tolerate the length of the 
study  with  their  bone  aches  and  they 
refused sedation. 
 
The cases came presented primarily  with 
regional  bone  aches,  (some  had 
accentuated regional bone aches on top of 
generalized  bone  aches)  and  other 
symptoms variably encountered including  
dyspnea  ,  jaundice,  disturbed 
consciousness  level    and  /or  other 
neurological manifestations. 
The 29 breast cases enrolled in the study 
were  in  either  of the following stages  of 
management: 
1)  Recent  diagnosis  prior  to 
commencement of therapy: 14 cases. 
2)  After  surgery  prior  to  commencement 
of CTH or RTH: 11 cases. 
3)  On  CTH  and  RTH  after  surgery:  2 
cases. 
4) On hormonal therapy after stoppage of 
post surgical CTH and RTH: 2 cases.  
5)  On  neoadjuvant  CTH  in  a  case  of 
advanced breast malignancy: 1 case. 
The  31  lung  cases  enrolled  in  the  study 
were  in  either  of the following stages  of 
management: 
1) On CTH and RTH without surgery: 15 
cases. 
2)  Recent  diagnosis  prior  to 
commencement of therapy: 10 cases.  
3) On CTH after surgery: 6 cases. 
The results of bone scans and whole body 
MR studies were either verified by follow 
up  or  by  biopsy  where  25  lesions  were 
biopsied  in  22  patients  (14  breast  cases 
and  8  lung  cases)  and  the  rest  were 
followed up.  
 
 
BONE SCAN RESULTS: 
A  total  of  158  lesions  were  reported  on 
bone scans, 71 lesions were vertebral, 43 
lesions  were  pelvic,  21  lesions  were 
thoracic,  16  lesions  were  in  the 
appendicular skeleton and 7 were calvarial 
as  plotted  in  the  graph  showing  the 
abundance of vertebral lesions. 
The  lesions  reported  with  confidence  as 
metastatic  included  59  vertebral  lesions, 
22  pelvic  lesions,  15  thoracic  lesions,  8 
appendicular  lesions  and  7  calvarial 
lesions  showing  the  prevalence  of 
confidently detected vertebral lesions. 
  As  for  the  equivocal  lesions,  they  were 
predominantly seen along the appendicular 
skeleton  falling  in  the  differential 
diagnosis of metastases, assymetric patchy 
marrow hyperplasia and osteonecrosis. 
Based on our study, the highest degrees of 
confidence  in  the  detection  of  metastatic 
osseous  lesions  were  encountered  with 
thoracic  metastasis  followed  by  calvarial 
and  vertebral  metastases,  while  the  least 
confidence  and  accordingly  the  more 
equivocal lesions were met with as regards 
the pelvic and appendicular lesions.  
Out  of  these  111  confidently  diagnosed 
metastatic  lesions,  19  turned  out  to  be 
false  positive    with  a  distribution  as 
displayed  in  the  pie  chart  (11  lesions 
confirmed by biopsy , 5 by disappearance/ 
appearing stationary without treatment on 
follow  up  studies  and  3  confirmed  not 
malignant on other imaging modalities). 
There  were  22  mismatched  lesions 
between bone scan and MRI that were not 
seen  on  bone  scan,  15  lesions  were 
confirmed  malignant;  6  through  biopsy 
and  histopathological  verification  and  9 
through progression on follow up. 
The  majority  of  those  15  false  negative 
lesions  on  bone  scan  were  appendicular 
followed  by  pelvic  lesions  as  plotted  on 
the pie chart with a distribution of 4 pelvic 
(2 confirmed on biopsy & 2 on follow up), 
7 appendicular (3 confirmed on biopsy & 
4 on follow up), 2 vertebral (1 confirmed 
Age  Male   Female   No of cases 
30 - 40 yrs  8  11  19 
41 - 50 yrs  6  14  20 
51 – 60 yrs  8  13  21 
Total  22  38  60 Wafaa Abdel Hamid 
205 
 
on  biopsy  &  1  on  follow  up)  and  2 
thoracic lesions confirmed on follow up. 
Collectively,  the  least  fallacies  including 
false  positive  and  false  negative 
interpretations  were  noted  as  regards  the 
calvarial  lesions,  followed  by  vertebral 
lesions, pelvic lesions, thoracic lesions and 
ending with appendicular lesions.  
Accordingly,  sensitivity,  specificity,  PPV 
and  NPV  were  calculated  regionally  to 
verify  the  accuracy  of  bone  scan  in 
detecting metastatic lesions based on their 
distribution as enclosed in table (2). 
 
Table (2): Collectively demonstrating the sensitivities, specificities, PPV's and NPV's of 
bone scan in detection of osseous metastases based on their distribution. 
 
WHOLE BODY MRI RESULTS: 
A  total  of  172  osseous  lesions  were 
reported on MRI without diffusion with a 
distribution  of  82  vertebral  lesions,  43 
pelvic, 33 appendicular, 10 thoracic and 4 
calvarial  lesions  with  an  abundance  of 
vertebral lesions. 
Out of those 172 lesions, 112 lesions were 
reported  malignant  with  confidence 
distributed  as  62  vertebral  lesions,  26 
pelvic lesions, 18 appendicular lesions, 4 
thoracic lesions and 2 calvarial lesions. 
On  adding  diffusion,  197  lesions  were 
detected with a distribution of 89 vertebral 
lesions,  50  pelvic,  38  appendicular,  16 
thoracic and 4 calvarial lesions. 
Out  of  which  134  lesions  were  reported 
malignant  with  confidence  with  a 
distribution  of  70  vertebral  lesions,  36 
pelvic lesions, 21 appendicular lesions, 5 
thoracic lesions and 2 calvarial lesions.   
At  first,  the  influence  of  adding  DWI  to 
WB-MRI is seen in the increase in number 
of lesions detected and is then emphasized 
through  comparing  the  percentage  of 
confidently detected lesions based on the 
opinion of an experienced MR reader with 
and without DWI. 
After  adding  DWI,  lesions  that  were 
confidently called metastatic raised to 134 
lesions.  As for the remaining 63 lesions; 
54 were considered benign and 9 lesions 
were equivocal. 
On comparing the equivocal lesions before 
and after adding DWI, 9 lesions remained 
equivocal, while the other 7 lesions were 
differentiated  into  2  benign  vertebral 
lesions  with  no  diffusion  restriction 
suggestive  of  osteoporotic  changes 
furtherly confirmed by DEXA. The other 5 
lesions were called metastatic attributed to 
their  frank  diffusion  restriction  with  low 
mean  ADC  values,  3  were  confirmed 
metastatic  by  biopsy  from  the  right  iliac 
bone, left femoral shaft and sacrum, as for 
the  remaining  2  lesions,  they  were 
vertebral  and  remained  unchanged  on 
follow up for which they were considered 
false positive  
Then there were the 25 lesions that were 
only seen on DWI's and not visualized on 
conventional  MR  images,  16  of  which 
were  not seen  on bone scan, 17 of these 
lesions  detected  only  on  diffusion  were 
true positive, 5 lesions were true negative 
and the remaining 3 were false positive.  
There was another mismatch between MRI 
and  bone  scan  with  the  lesions  being 
inconspicuous on MRI. 
20  lesions  were  inconspicuous  on  MR 
images  (without  diffusion)  although 
demonstrated on Bone Scan and reported 
as malignant, 14 of which were verified to 
be false negative on MRI/true positive on 
Bone Scan; 1 was biopsied from a vertebra 
and histopathologically verified, the other 
13 lesions were verified through follow up 
studies, either showing regression on post 
therapy follow up or progression on follow 
up  without  therapy),  the  other  6  lesions 
were verified as false positive; 2 by biopsy 
from  femoral  and  pelvic  lesions  and  the 
Calvarial 
lesions 
Appendicular 
lesions 
Thoracic 
lesions 
Pelvic 
lesions 
Vertebral 
lesions 
 
100%  69.8%  81.8%  85.1%  91.6%  Sensitivity 
76.6%  28.5%  60%  56.2%  66.6%  Specificity 
80%  58.3%  81.8%  76.6%  91.9%  PPV 
100%  22.8%  60%  69.2%  80%  NPV A Comparative Study … 
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other  4  confirmed  benign  by  follow  up 
studies. 
On  adding  diffusion,  these  mismatched 
lesions  came  down  to  14  lesions  that 
remained inconspicuous while the other 6 
lesions  included  3  vertebral  metastatic 
deposits,    faint  diffusion  restriction  at  a 
left femoral head that was confirmed on a 
follow up MR study to be early avascular 
necrosis and two other pelvic lesions that 
turned  out  to  be  patchy  marrow 
hyperplasia.  The  fate  of  these  lesions  is 
demonstrated in table (19).  
On WB-MRI without diffusion 91 lesions 
are  true  positive,  18  lesions  are  false 
positive, 34  lesions are true  negative, 14 
lesions  are  false  negative  and  16  lesions 
are equivocal.  
Then  on  WB-MRI  with  diffusion,  119 
lesions  are  true  positive,  13  lesions  are 
false positive, 41 lesions are true negative, 
11 lesions are false negative and 9 lesions 
are equivocal.  
Statistical  analysis  in  the  form  of 
sensitivity, specificity, PPV and NPV are 
compared  between  bone  scan  and  WB-
MRI  with  and  without  diffusion 
highlighted in table (2). 
WB-MRI with 
diffusion 
WB-MRI without 
diffusion 
Bone Scan   
88.9%  73.4%  85.6%  Sensitivity 
82.9%  68.8%  67.5%  Specificity 
93%  78.1%  61.7%  PPV 
69%  62.6%  66.3%  NPV 
Table  (2):  comparing  global  sensitivies, 
specificities,  PPV's  and  NPV's  of  bone 
scan, WB-MRI without diffusion and WB-
MRI with diffusion in detection of osseous 
metastases. 
Quantitative analysis of the diffusion study 
showed  variable  degrees  of  overlap  in 
ADC  values  between  the  different 
pathological entities.  
There is an overlap between the Low ADC 
values of red marrow and metastasis at the 
range  of 0.61 to 0.69 x10
-3  mm
2/sec and 
then between metastasis and other benign 
pathological  marrow  entities at the range 
of 0.9 to 1.03 x 10
-3 mm
2/sec sparing the 
midrange  of  0.7  to  0.89  x  10
-3  mm
2/sec 
where  only  metastatic  lesions  gave  these 
values in our study. 
 Biopsy helped in verifying the following 
25  lesions  (10  pelvic,  6  femoral,  6 
vertebral, 2 tibial and 1 sternal) distributed 
as follows: 
The forementioned results are representing 
one sector of the study which is considered 
the main sector, but then there is another 
parallel  sector  of  major  influence  on 
patient's  management  and  therapeutic 
planning which is related to the detection 
and  verification  of  soft  tissue  metastatic 
involvement  and  comparing  results  of 
MRI with and without DWI. 
Conventional MR images revealed: 
1)  23 hepatic focal lesions in 14 cases.  
2)    19  lymph  nodes  suggested  to  be 
metastatic,  11  were  axillary  in  7  breast 
cases  and  8  were  hilar/mediastinal  in  4 
lung cases. 
3)    9  suggested  adrenal  metastases  in  7 
cases of lung cancer with a confidence in 
diagnosing 7 of these lesions.  
4)    2  cases  were  suggested  to  have 
leptomeningeal infiltrates, one spinal and 
one  intracranial  with  the  latter  being 
merely conspicuous. 
5)  1 case of breast cancer showed renal 
metastasis.  
6) 2 cases showed lesions suggested to be 
intramuscular  soft  tissue  metastatic 
deposits,  two at left calf muscles in one 
case  and  one  at  medial  muscular 
compartment  of  the  left  thigh  in  another 
patient.  
7) 5 cases of breast cancer and 4 cases of 
lung  cancer  showed  pulmonary  nodules 
(about 16) suggested to be metastatic. 
8) 5 cases (3 breast cases and 2 lung cases) 
showed  uneven  pleural  thickening,  3  of 
which  were  suspicious  of  a  metastatic 
nature and 2 were suggested to be benign 
post irradiation pleural thickenings.  
9) 12 cases showed 18 brain lesions best 
demonstrated on post contrast images with 
about  12  being  confidently  diagnosed  as 
metastatic. 
On adding  diffusion to  conventional MR 
images, it had the following influence on Wafaa Abdel Hamid 
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the  detection and  characterization  of soft 
tissue lesions:  
1) - 31 hepatic focal lesions in 16 cases, 11 
were breast cases and 5 were lung cases.  
2)  -  22  lymph  nodes  suggested  to  be 
metastatic,  12  were  axillary  and  1 
supraclavicular  in  7  breast  cases  and  9 
were hilar/mediastinal in 6 lung cases.   
3)  10 suggested adrenal  metastases in 7 
cases of lung cancer with a confidence in 
diagnosing 9 of these lesions.      
4)    3  cases  were  confidently  called 
leptomeningeal infiltrates, one spinal and 
two intracranial (one of which was merely 
conspicuous on conventional MR images). 
5)    1  case  of  breast  cancer  with  renal 
metastasis.  
6) The 3 intramuscular soft tissue lesions 
that were seen on conventional MRI; the 
two  left  calf  lesions  still  remained 
equivocal  due  to  the  overlap  in  ADC 
values between a chronic hematoma and a 
soft tissue. 
7) 6 cases of breast cancer and 4 cases of 
lung  cancer  showed  23  pulmonary 
nodules. 
8) 7 cases (5 breast cases and 2 lung cases) 
showed uneven pleural thickening, 3  were 
suggested  metastatic  appearing  as  an 
irregular  hypointense  rim  on 
corresponding  ADC  maps  giving  a  low 
mean ADC value. 
9) The 12 lesions reported metastatic out 
of  the  18  brain  lesions  on  conventional 
MRI were supported metastatic on DWI. 
  The majority of soft tissue lesions were 
verified on follow up and only the left calf 
intramuscular  lesions,  the  left  renal 
metastasis and an adrenal metastasis were 
verified by biopsies. 
WB-MRI with diffusion came superior to 
WB-MRI  without  diffusion  in  the 
detection of: 
1)8  extra  hepatic  focal  lesions  (6 
metastatic) and adding 2 more patients. 
2)3 extra metastatic lymph nodes. 
3)1 extra adrenal metastasis in a case with 
no other soft tissue metastases. 
4)1 extra leptomeningeal metastasis and an 
extra case was added. 
5)7 extra pulmonary nodules. 
6)2 extra cases with pleural thickenings. 
Although DWI showed a high sensitivity 
(94% & 86%)  in the detection  of  lymph 
nodes and pulmonary nodules respectively 
yet  it  showed  a  low  specificity  (55%  & 
52%) in the differentiation between benign 
and  malignant  lymph  nodes  and 
pulmonary nodules respectively.  
Two  of  the  confidently  called  metastatic 
pleural  thickenings  on  MRI  with  and 
without  diffusion  turned  out  to  be  false 
positive  and  suggested  to  be  post 
irradiation  fibrosis  based  on  a  one  year 
follow up stationary course. 
This is an example of a case show osseous 
and  soft  tissue  metastatic  lesions;  a  42  - 
year-  old  female  patient  with  recently 
diagnosed  breast  cancer  was  presented 
with lower back pain, right sciatica. 
Her bone scan revealed osseous metastases 
at  D1  and  L2.  On  correlation  with  her 
WB-MRI, it showed osseous metastases at 
C5,  D1 and  L2.  The  L2  vertebral  lesion 
showed  an  extra-osseous  soft  tissue 
component  intra  and  retrospinal 
compromising  L2/L3  neural  foramen, 
implicating right L3 nerve root. Her MR 
study  more  so  her  DWI  showed  2 
metastatic  pulmonary  nodules  as 
demonstrated in figures (1) and (2). 
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Figure (1): A case of metastatic breast cancer. (A) The patient's anter and posterior projections, bone scan showed focal 
zones of hot uptake at D1, L2 and right aspect of the manubrium sterni. (B) Sagittal T1W image of the dorsolumbar 
spine showed a sizable hypointense marrow lesion implicating the right posterolateral aspect of L2 vertebra and pedicle 
with expansion and extra-osseous soft tissue component furtherly demonstrated on (C) axial T2W image at L2 level 
showing the right sided infiltrative process with intra and retrospinal soft tissue extensions.(D) Sagittal T1W image of 
the cervical spine showing hypointense metastatic lesions at C5 and D1. 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure (2): The same case of metastatic breast cancer showing (A) WB-MRI coronal T1W image 
showing the primary breast lesion seen at upper inner quadrant of the right breast exhibiting dark signal 
and showing irregular outlines. (B) Corresponding axial inverted DWI showing the breast lesion as a 
A  B 
C 
D 
D 
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flared out zone of evident diffusion restriction, giving a mean ADC value of 0.91 x 10
-3 mm
2/sec. (C) & 
(D) are also axial inverted DWI's at different levels showing the pulmonary nodules as rounded focal 
zones of diffusion restriction at lateral segment of right middle lung lobe (C) and posterior segment of 
left lower lung lobe (D) giving a low mean ADC value ranging between 0.97 and 1.03 x 10
-3 mm
2/sec. 
 In this case we can see that bone scan detected a sternal metastasis not conspicuous on MRI confirmed 
on follow up and the WB-MRI with diffusion showed a small lesion at C5 vertebra, a soft tissue 
component in association with the L2 lesion implicating right L3 nerve root and two pulmonary 
metastatic nodules.   
DISCUSSION 
Based  on  our  study,  the  confidence  of 
detection  and  characterization  of  skeletal 
metastases  on  bone  scan  was  scaled  as 
thoracic  including  rib  and  sternal  lesions 
being  the  highest  (93.7%)  with  the  least 
percent  of  equivocal  lesions  (5.2%), 
followed by vertebral and calvarial lesions 
(86%  &  87.5%  respectively)  with  a 
percent  of  equivocal  lesions  (12.6%  & 
12.5% respectively), then we have pelvic 
lesions  (72.7%)  with  a  percent  of 
equivocal lesions (26%) and last we have 
the  appendicular  lesions  (57%)  with  a 
percent of equivocal lesions (35.4%). 
 
According  to  this,  we  are  proposing  that 
skeletal  scintigraphy  is  much  better 
established  for  the  detection  and 
characterization  of  thoracic  lesions 
followed by vertebral and calvarial lesions 
all the way down to appendicular lesions 
where bone scan wouldn't be the study of 
choice when it comes to decision making 
in patient management. 
 
This  is  furtherly  translated  through 
sensitivity,  specificity,  PPV  and  NPV 
calculated  according  to  regional 
distribution  of  lesions,  with  the  highest 
values  noted for calvarial lesions (100%, 
76.6%,  80%  &  100%  respectively) 
followed  by  vertebral  lesions  (91.6%, 
66.6%, 91.9% & 80% respectively), then 
pelvic  lesions  (85.1%,  56.25,  76.6%  & 
69.2%  respectively)  and  thoracic  lesions 
(81.8%,  60%,  81.8%and  60% 
respectively)  being  more  or  less 
comparable  and  last  come  appendicular 
lesions  (69.8%,  28.5%,  58.3  &  22.8% 
respectively). 
 
Another study addressing the accuracy of 
bone  scan,  concluded  that  it  had  a 
sensitivity  of  88.4%  in  vertebral  lesions, 
74% in pelvic lesions, 66.9% in calvarial 
lesions, 61% in thoracic lesions and 48% 
in appendicular lesions. [5] 
 
Ryoto  et  al's  results  were  comparable  to 
our study concluding that bone scan had a 
high diagnostic accuracy in vertebral and 
calvarial lesions followed by thoracic and 
pelvic lesions and last in long bones.[6] 
 
 
One of these cases that had false positive 
lesions was rather interesting having a rare 
autosomal dominant bone disorder known 
as    Osteopoikilosis  where  the  bone  scan 
showed hot foci at the left femoral head, 
the  corresponding  MR  study  showed 
multiple rounded sclerotic bone lesions of 
more or less the same size at both hip joint 
regions  (acetabular  bones  and  femoral 
heads)  appearing  hypointense  on  T1W 
images,  hardly  conspicuous  on  STIR 
showing no diffusion restriction as seen in 
figure (3).  
 
What was interesting in this case was that 
the patient was complaining of persistent 
back  pain  and  was  a  recently  diagnosed 
case of lung cancer. His bone scan came 
negative  for  any  vertebral  metastases 
while  his  MR  study  showed  a  lumbar 
lesion that was called metastatic attributed 
to patient's symptomatology and being an 
uncommon  site  of  involvement  for 
osteopoikilosis and furtherly confirmed by 
biopsy. 
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Figure (3): A known case of lung cancer for which patient was subjected to CTH and surgical 
resection and became tumor free for a year then started complaining of bone aches at his lower back 
and pelvis. (A) Anterior and posterior projections bone scan showed left femoral head enlargement 
with small focal zones of hot uptake reported metastatic. A small zone of warm up take is seen high 
cervical to the left and was suggested facetal arthropathy. (B) The patient\s WB-MRI T1W coronal 
image showed an L2 metastatic marrow lesion exhibiting dark signal. It was not seen on bone scan 
furtherly demonstrated on 3D coronal MIP of the patients inverted DWI (C) showing a discreet focus 
of diffusion restriction to the left of L2 vertebra giving a low mean ADC value of 0.86 x 10
-3 mm
2/sec.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure (4): The same case showing (A) Coronal T1W image of the pelvis revealing multiple more or 
less same sized discreet foci of sclerosis at both acetabular bones and femoral heads typical for 
osteopoikylosis. Not seen on Coronal DWI of the pelvis (B) while a lesion showing diffusion 
restriction is demonstrated at left pubic bone (red arrow giving a low mean ADC value of 0.74 x 10
-3 
mm
2/sec. There other zones of diffusion restriction corresponding to the symphsis pubis (yellow arrow) 
giving higher mean ADC values ranging between 1.03 and 1.12 x 10
-3 mm
2/sec suggested to be 
secondary to ostieitis pubis. Those lesions were not conspicuous neither on conventional MRI nor on 
bone scan. 
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The 15 false negative lesions on bone scan were predominantly lytic (11), two of which were 
aggressive pelvic and vertebral lesions. These lesions were encountered as 7 appendicular, 4 
pelvic, 2 vertebral and 2 thoracic. 
Collectively, we found out that bone scan gave an overall sensitivity of 85.6%, specificity of 
67.5%, PPV of 61.7% and NPV of 66.3%. 
Those findings were partly noted in our study where most of the thoracic lesions (12 out of 
15) were seen in breast cancer cases and then 5 of the 8 appendicular lesions delineated on 
bone scan were in lung cancer cases. 
As for the WB-MRI study, it was assessed with and without diffusion to verify whether or not 
it was worth adding an extra 25-30 minutes to the study. 
WB-MRI without diffusion detected 172 lesions distributed as 82 vertebral, 43 pelvic, 33 
appendicular, 10 thoracic and 4 calvarial. Out of these lesions, 112 lesions were confidently 
reported metastatic with a distribution of 62 vertebral, 26 pelvic, 18 appendicular, 4 thoracic 
and 2 calvarial. The remaining 60 lesions were considered benign (44 lesions) or equivocal 
(16 lesions). 
On adding diffusion, 197 lesions were detected with an extra of 25 lesions. 17 of these extra 
lesions were of significance proven metastatic (2 by biopsy and 15 by follow up) and 3 other 
lesions turned out false positive (2 by biopsy and 1 by follow up). The remainder 5 lesions 
were true negative for metastases. Those lesions were met with in 14 patients.  
There was another mismatch but this time the lesions were seen on bone scan and not on 
MRI, they were 20 lesions on WB-MRI without diffusion and came down to 14 lesions on 
adding DWI.  
It is worth mentioning that the majority of missed lesions (9) on MRI were in one case having 
diffusely accentuated red marrow signal attributed to chronic anaemia obscuring the lesions 
(metastasis was suspected by the reporter, but distinct specific lesions couldn't be verified) as 
demonstrated in figure (5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure (5): A known case of metastatic breast cancer. (A)Anterior and posterior projections bone 
scan showed a heavy metastatic load implicating the spine, pelvis and ribs. (B) Sagittal T1W image of 
the whole spine showed diffusely hypointense vertebral marrow with a sense of inhomogeneity, no 
definite lesions could be delineated. (C) Sagittal post contrast T1W image with fat suppression showed 
diffuse heterogeneity of contrast enhancement with equivocal lesions seen at the lumbar spine. This 
was a case with chronic anaemia and metastases on to. It was rather tricky on MRI. 
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After  establishment  of  the  diagnosis 
through biopsy or follow up, on WB-MRI 
without  diffusion  91  lesions  were  true 
positive,  18  lesions  false  positive,  34 
lesions  true  negative,  14  lesions  false 
negative  and  16  lesions  were  equivocal. 
Then  on  WB-MRI  with  diffusion,  119 
lesions were true positive, 13 lesions false 
positive,  41  lesions  true  negative,  11 
lesions  false  negative  and  9  lesions 
remained equivocal. 
Bone scan  has a higher accuracy for the 
detection and characterization of vertebral 
and calvarial lesions while it wouldn't be 
the  modality  of  choice  for  appendicular 
lesions. 
On the other hand, WB-MRI has a higher 
accuracy  for  the  detection  and 
characterization  of  pelvic,  appendicular 
followed  by  vertebral  lesions  while  it 
wouldn't  be  the  modality  of  choice  for 
calvarial  lesions.  As  for  thoracic  lesions, 
we  found  out  that  DWI  improved  their 
detection through 3D MPR and thick stack 
coronal MIP's. 
Globally, on comparing sensitivities; bone 
scan  was  85.6%,  WB-MRI  without 
diffusion  was  73.4%  and  WB-MRI  with 
diffusion  88.9%.  On  comparing 
specificities; bone scan  was 67.5%, WB-
MRI  without  diffusion  was  68.8%  and 
WB-MRI  with  diffusion  was  82.9%.  On 
comparing PPV's; bone scan  was 61.7%, 
WB-MRI  without  diffusion  was  78.1% 
and WB-MRI with diffusion was 93%. On 
comparing NPV's; bone scan was 66.3%, 
WB-MRI  without  diffusion  was  62.6% 
and WB-MRI with diffusion 69%.[7] 
We  compared  these  results  with  other 
studies,  the  majority  of  which  didn't 
employ  diffusion  studies  and  only 
included  STIR  and  T1W  sequences  with 
and without contrast. 
The  first  comparative  study  between 
whole-body MRI using turbo spin imaging 
and  planar  skeletal  scintigraphy  was 
carried  out  in  1997  by  Eustace  et  al.  A 
total  of  25  patients  with  various  tumor 
types were examined. The authors reported 
96.5% sensitivity and 100% specificity for 
whole  body  MRI.  Planar  skeletal 
scintigraphy as the established method had 
a  sensitivity  of  72%  and  a  specificity  of 
98%.[8] 
Steinborn et al. examined 18 patients with 
various  malignant  primary  diseases  and 
suspicion  of  bone  metastases  with  an 
examination  protocol  that  incorporated 
STIR  imaging  and  a  T1-weighted  spin-
echo  sequence.  The  whole-body  MRI 
detected 91.4% of the metastases that were 
verified during the course of the disease, 
whereas  skeletal  scintigraphy  only 
revealed 85% of lesions.[9] 
We  found  out  that  adding  diffusion  to 
conventional MR sequences improved the 
conspicuity  of  rib  lesions,  this  was 
supported  in  Xian  Xu,  et  al's  study  that 
also  concluded  that  DWI  had  no 
significant influence  on the sensitivity of 
MRI for calvarial lesions.[10] 
 Despite  the  statistical  values  favouring 
DWI, we  have to admit that  establishing 
the diagnosis based on follow up is not a 
100%  accurate  method  especially  in 
stationary  lesions  and  regressive  lesions 
without  therapy  but  again  the  gold 
standard  of  histopathological  verification 
is not feasible for all suspected metastatic 
lesions.  
By incorporating DWI, our study could be 
considered a dual study going on parallel 
to  each  other  comparing  MRI  as  a 
multiparametric  upgraded  protocol  with 
Bone scan and at the same time comparing 
the  reproducibility  of  MRI  with  and 
without DWI in the  detection  of  osseous 
and soft tissue metastases. 
Assessment of lesions included qualitative 
assessment  of  lesions  based  on  signal 
intensity  on  ADC  maps,  the  more 
hypointense the lesion the more suggestive 
of cellular packing and thus of metastases 
and quantitative assessment through ADC 
values. 
There were variable degrees of overlap in 
ADC  values  between  the  different 
pathological  entities,  the  ones  of 
significance  are  those  intersecting  with 
metastases,  where  there  is  an  overlap 
between  the  Low  ADC  values  of  red 
marrow and metastasis at the range of 0.61 
to  0.69  x10
-3  mm
2/sec  and  then  between 
metastasis  and  other  benign  pathological 
marrow entities at the range of 0.9 to 1.03 
x 10
-3 mm
2/sec sparing the midrange of 0.7 
to 0.89 where only metastatic lesions gave 
these values in our study. Wafaa Abdel Hamid 
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Another study showed Mean ADCs of the 
normal bone marrow, 0.57 ± 0.20 and 0.29 
± 0.15 × 10
–3 mm
2/s, for red and yellow 
marrow  respectively  and  a  mean  ADC 
value  of  0.61  +/-  0.21×  10
–3  mm
2/s  for 
metastatic lesions.[10] 
 
Through all the studies - we came across - 
that  tackled  quantitative  assessments  of 
diffusion through ADC values, there was 
no sole cut off value; each study showed a 
degree of overlap between normal marrow, 
benign  and  malignant  lesions.  We 
concluded in our study that a mean range 
of 0.7 to 0.89 x 10
-3 mm
2/sec was found in 
metastatic lesions only but then relying on 
these values to call for metastases in any 
patient  would  be  unwise  because  of  the 
influence  of  underlying  marrow  being 
predominantly yellow or red and the lesion 
itself  being  lytic,  sclerotic  or  mixed  that 
could significantly alter these values. 
Biopsy  was  accessible  in  25  lesions, 
mainly undergone to verify  descripancies 
between  both  modalities  in  lesions  that 
would  have  an  impact  on  management 
strategies. 
Biopsy also played a role in this study to 
assess  reliability  of  DWI  as  a  sole 
diagnostic  tool  with  lesions 
indistinguishable/inconspicuous  on 
conventional MRI and bone scan.  
The forementioned results are representing 
one sector of the study which is considered 
the main sector, but then there is another 
parallel  sector  of  major  influence  on 
patient's  management  and  therapeutic 
planning which is related to the detection 
and  verification  of  soft  tissue  metastatic 
involvement  and  comparing  results  of 
MRI with and without DWI. 
DWI  was  capable  of  detecting  6  more 
hepatic lesions. It added two more patients 
that  were  not  diagnosed  with  hepatic 
metastases  and  thus  influencing  their 
therapeutic strategies. 
 
An  extra case with an adrenal  metastasis 
was diagnosed only on DWI, this case had 
no other soft tissue metastatic lesions and 
so this input was of major importance in 
management planning. 
A vast number of studies have assessed the 
role  of  DWI  in  the  detection  and 
characterization  of  hepatic  and  adrenal 
lesions. 
Li et al compared DWI with standard T2W 
sequence  in  the  detection  and 
characterization  of  hepatic  focal  lesions 
revealing  an  overall  detection  rate 
(averaged for two observers) significantly 
higher  for  DW  (87.7%)  versus  T2-
weighted (70.1%) imaging (P < .001). FLL 
characterization  was  not  significantly 
different  between  DW  (89.1%)  and  T2-
weighted  (86.8%)  imaging  (P  =  .51). 
ADCs  of  malignant  FLLs  were 
significantly  lower  than  those  of  benign 
FLLs (P < .001).[11] 
An  extra  case  with  metastatic 
leptomeningeal  infiltration  in the base  of 
the  skull  was  only  detected  on  DWI 
adding  to  patient's  metastatic  load.  This 
patient showed dramatic disappearance of 
the  leptomeningeal  infiltration  after  3 
months post CTH.  
The  majority  of  soft  tissue  lesions  were 
verified on follow up and only the left calf 
intramuscular  lesions,  the  left  renal 
metastasis and an adrenal metastasis were 
verified by biopsies. 
Bone  scan  played  a  limited  role  in 
detection  of soft tissue lesions  with  only 
one  of  the  cases  showing  abnormal  skin 
and soft tissue uptake at both calf regions. 
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Figure (6): A case of lung cancer with paraneoplastic syndrome. (A) Anterior projection bone scan 
shows a metabolic superscan with non visualization of the kidneys and preferential diffuse hot uptake 
of the calvarium and sternum. There is abnormal hot uptake at left iliac bone and left femoral head and 
proximal shaft. There is also abnormal uptake at the skin of both legs (calf regions). (B) WB-MRI T1W 
coronal image showing marrow infiltration at left iliac bone and left femur (arrowheads). (C) sagittal 
T1W and (D) sagittal post contrast T1W with fat suppression images of the left calf region showing a 
heterogenous gastrocnemeus soft tissue lesion histopathologically confirmed to be metastatic. 
 
Our attempt was to help place guidelines for oncologists in the triaging of cancer patients, as 
to which imaging modality they would benefit the most sparing them the loss of unnecessary 
time and money and pointing out choices that would directly influence their management 
planning and prognosis.  
 
CONCLUSION 
We don't think that WB-MRI should replace bone scan in the quest for skeletal metastases. 
However, we believe that WB-MRI should be the modality of choice when both skeletal and 
soft tissue metastases are suspected and in the follow up of a known metastatic patients for 
adequate coverage of both skeletal and soft tissue structures combined with qualitative and 
quantitative  features  of  DWI  helping  assess  tumors  at  cellular  levels  even  prior  to  gross 
morphological changes verifying response to therapy as early as possible sparing patients 
precious time  from drifting with delayed decision making. 
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